Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) EBITDA Margin (2020 - 2025)

Sotera Health has reported EBITDA Margin over the past 6 years, most recently at 16.65% for Q4 2025.

  • Quarterly results put EBITDA Margin at 16.65% for Q4 2025, up 4122.0% from a year ago — trailing twelve months through Dec 2025 was 15.16% (up 2162.0% YoY), and the annual figure for FY2025 was 15.16%, up 2162.0%.
  • EBITDA Margin for Q4 2025 was 16.65% at Sotera Health, up from 10.02% in the prior quarter.
  • Over the last five years, EBITDA Margin for SHC hit a ceiling of 30.28% in Q2 2025 and a floor of 104.29% in Q4 2022.
  • Median EBITDA Margin over the past 5 years was 2.86% (2021), compared with a mean of 0.35%.
  • Biggest five-year swings in EBITDA Margin: skyrocketed 15715bps in 2021 and later plummeted -12826bps in 2022.
  • Sotera Health's EBITDA Margin stood at 23.98% in 2021, then plummeted by -535bps to 104.29% in 2022, then soared by 119bps to 19.38% in 2023, then tumbled by -227bps to 24.57% in 2024, then skyrocketed by 168bps to 16.65% in 2025.
  • The last three reported values for EBITDA Margin were 16.65% (Q4 2025), 10.02% (Q3 2025), and 30.28% (Q2 2025) per Business Quant data.